Leiomyosarcoma removal in China typically costs between $7,500 and $15,000. Prices vary based on tumor location, surgical technique, and hospital tier. In the US, similar procedures cost around $58,500 on average. Patients save around 81% compared to US rates. Surgical costs generally include pre-operative consultations, the procedure, and hospital stays in major hubs like Guangzhou, Beijing, and Shanghai.
Bookimed Expert Insight: China offers high-value oncology care through specialized centers like Fuda Cancer Hospital. They pioneered NanoKnife technology in China, which is FDA and EU approved. This expertise attracts patients from over 100 countries seeking advanced ablation techniques. Specialized hospitals often provide free interpreters and airport transfers to simplify international patient logistics. Choosing a Joint Commission International (JCI) accredited facility ensures safety standards match Western institutions at lower costs.
| China | Turkey | Austria | |
| Leiomyosarcoma Removal | ≈ $7,500 | ≈ $7,500 | ≈ $11,500 |
No hidden fees – just official clinic prices. Pay at the clinic for Leiomyosarcoma Removal upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Leiomyosarcoma Removal and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Leiomyosarcoma Removal journey.
Day 1
Day 2
Day 3
Day 4
Day 5 and 6
Day 7
Week 2 to 4
Week 5 to 8
Please note that each patient"s recovery timeline and experience may vary based on individual factors, including the extent of the tumor and overall health.
Dr. Niu Lizhi is the President and chief surgeon at Fuda Cancer Hospital in Guangzhou. He has performed nearly 10,000 cryosurgeries and 500 NanoKnife procedures. Dr. Niu specializes in minimally invasive oncology for lung, pancreatic, and liver cancers. He treats patients ranging from early childhood through age 94.